Evergreen Hematology and Oncology is a clinical research site located in Spokane, Washington, United States 99218.
Crixeo Health Trust Score: 75/100 (FAIR). This profile has not yet been claimed by the site owner.
Evergreen Hematology and Oncology has participated in 7 clinical trials.
Therapeutic areas: Metastatic Breast Cancer, HER-2 Gene Amplification, Stage IV Pancreatic Cancer.
Sponsors: Translational Drug Development, Merrimack Pharmaceuticals, Pancreatic Cancer Research Team.
Trust Score: 75/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Evergreen Hematology and Oncology has a Crixeo Trust Score of 75/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Evergreen Hematology and Oncology has 7 clinical trials on record. Their work covers Metastatic Breast Cancer, HER-2 Gene Amplification, Stage IV Pancreatic Cancer.
Yes — Evergreen Hematology and Oncology holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.